Helvetica Chimica Acta ± Vol. 86 (2003)
1757
Experimental Part
1
. Synthesis and Characterisation of Homogeneous Catalysts. All compounds were purchased from Aldrich,
unless otherwise stated. The solvents were all predried by standard methods. The reactions were carried out
under a N atmosphere by standard Schlenk line techniques. The NMR measurements were performed on a
Bruker DPX (500 MHz) employing cryo-probe technology or a Bruker 400-MHz spectrometer.
Rh(Cycloocta-1,5-diene){(S,S,S)-dipof}]CF SO (2a). [RhCl(cod)] (46 mg, 0.09 mmol) was dissolved in
THF (5 ml), to which AgCF SO (37 mg, 0.19 mmol) was added, and this soln. was stirred for 1 h at r.t. The soln.
2
[
3
3
2
3
3
was then filtered (to remove AgCl), and to the filtrate (S,S,S)-dipof (1a; 110 mg, 0.19 mmol) was added, and the
soln. left to stir for 1 h. Then, the soln. was slightly concentrated in vacuo, and hexane (25 ml) was added to
precipitate the required product. The soln. was filtered and the product washed with hexane (2 Â 20 ml) and
1
Et
2
2
O (2 Â 20 ml), and dried in vacuo: 2a (100 mg, 55%). Orange powder. H-NMR (CDCl
3
, 400 MHz): 1.79 ±
.72 (m, 8 H); 3.40 (m, 1 H); 3.65 (m, 1 H); 3.74 (m, 1 H); 4.77 (s, 5 H); 4.80 (m, 1 H); 5.05 (m, 1 H); 5.15
m, 1 H); 5.18 (m, 1 H); 5.28 (m, 1 H); 5.45 (m, 1 H); 6.64 ±7.73 (m, 20 H). P-NMR (CDCl
3
1
(
(
3
): 23.9
1
d, J(P,Rh) 149.8). ESI-MS (pos.): 803 (100).
[
Rh(Cycloocta-1,5-diene)(l-tryptophan Benzyl Ester)]CF
3
SO
(62 mg, 0.24 mmol) was added and the soln. was stirred for 1 h at
r.t. The soln. was then filtered (to remove AgCl) and to the filtrate l-tryptophan benzyl ester (1b; 72 mg,
.24 mmol) was added, and the soln. was left to stir for 1 h. Then, the soln. was slightly concentrated in vacuo,
and hexane (25 ml) was added to precipitate the required product. The soln. was filtered, and the product was
3 2
(2b). [RhCl(cod)] (60 mg, 0.12 mmol) was
3 3
dissolved in THF (5 ml) to which AgCF SO
0
washed with hexane (2 Â 20 ml) and dried in vacuo. The residue was recrystallized in CH
2 2
Cl to give 2b (121 mg,
, 400 MHz): 1.50 ± 1.69 (m, 4 H, cod); 2.09 ± 2.30 (m, 4 H, cod); 3.25
1
7
7%). Yellow crystals. H-NMR (CD
2
Cl
2
3
3
(
d, J 6.0, CH
2
CH); 3.58 (m, 4 H, cod); 4.15 (t, J 6.0, CH
2
CH); 5.26 (s, CH
2
O); 7.16 ± 7.72 (m, 10 H, Ph,
CH); 69.9 (CH O);
1
3
C
8
H
6
N); 9.28 (s, NH). C-NMR (CD
2
Cl
2
): 29.5, 30.8 (CH
2
, cod); 30.1 (CH CH); 56.3 (CH
2
2
2
8
1
4
2.9 (d, J(Rh,C) 63, CH, cod); 103.2, 112.5, 119.0, 119.6, 120.4, 121.2, 122.2, 124.5, 129.0, 129.3, 129.4, 134.3,
38.0 (Ph and C RhS: C 49.55, H
N); 179.3 (CO). ESI-MS (pos.): 505 (85%). Anal. calc. for C27
.62, N 4.28; found C 48.42, H 4.57, N 4.05.
Rh{(À)-(S)-2-(Aminomethyl)-1-ethylpyrrolidine}(cycloocta-1,5-diene)]CF
100 mg, 0.20 mmol) was dissolved in THF (10 ml), to which AgCF SO (104 mg, 0.40 mmol) was added, and
this soln. was stirred for 1 h at r.t. The soln. was then filtered (to remove AgCl) and to the filtrate ( À )-(S)-2-
aminomethyl)-1-ethylpyrrolidine (1c; 52 mg, 0.40 mmol) was added, and the soln. was left to stir for 1 h. Then,
the soln. was slightly concentrated in vacuo, and hexane (25 ml) was added to precipitate the required product.
8
H
6
30 3 2 5
H F N O
[
3
SO
3
(2c). [RhCl(cod)]
2
(
3
3
(
The soln. was filtered, and the product was washed with hexane (2 Â 20 ml) and Et
2
O (2 Â 20 ml), and dried in
vacuo: 2c (172 mg, 88%). Yellow powder.
1H-NMR (CDCl
): 1.54 (t, J 7, Me(1)); 1.74 (br. s, 2 CH
(cod)); 1.80 ± 2.09 (m, CH
(3)); 2.90 (m, CH(6)); 3.10 (m, CH
(7)); 3.57 (d, J(Rh,H) 37,
): 12.2 (C(1)); 21.7 (C(4)); 24.4 (C(5)); 29.6
3
2
2 2
(4), CH (5)); 2.30 (br.
1
s, 2 CH
2
(cod)); 2.45 ± 2.70 (m, CH
2
(2), CH
2
2
1
13
2
CH (cod)); 3.75 (d, J(Rh,H) 74, 2 CH (cod)). C-NMR (CDCl
3
(
(
(
d, J(Rh,C) 12, CH
2
(cod)); 30.5 (d, J(Rh,C) 36, CH
2
(cod)); 45.5 (C(7)); 50.9 (C(2)); 56.5 (C(3)); 67.1
C(6)); 79.6 (d, J(Rh,C) 65, CH (cod)); 83.6 (d, J(Rh,C) 240, CH (cod)). ESI-MS (pos.): 339 (M ), 231
[M À cod] ). Anal. calc. for C16
28 3 2 3
H F N RhSO : C 39.34, H 5.74, N 5.74; found: C 39.84, H 5.54, N 5.69. Crystals
2 2 2
suitable for X-ray diffraction were obtained by recrystallisation in CH Cl /Et O.
[
Rh(Cycloocta-1,5-diene){()-(1R,2R)-1,2-diphenylethan-1,2-diamine}]CF
3
SO
3
(2d). [RhCl(cod)]
2
(
100 mg, 0.20 mmol) was dissolved in THF (10 ml), to which AgCF
3
SO
3
(104 mg, 0.40 mmol) was added, and
this soln. was stirred for 1 h at r.t. The soln. was then filtered (to remove AgCl) and to the filtrate ()-(1R,2R)-
1,2-diphenylethane-1,2-diamine (1d; 83 mg, 0.40 mmol) was added, and the soln. was left to stir for 1 h. Then, the